The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Our lab studies how interrelated organ systems such as heart, kidney and liver regulate cellular damage (particularly inflammation and fibrosis) and repair during the course of chronic ailments such as heart failure, hypertension, diabetes, obesity and chronic kidney disease. We are particularly interested in developing new preventative and therapeutic strategies to help people suffering from these diseases through establishing novel biomarkers and molecular diagnostics to assist risk stratification as well as identifying new drugs and drug targets and enhancing endogenous counter-regulatory mechanisms. Given our community’s ties to and dependence on the Great Lakes as a source of clean water for drinking, recreation, fishing and agriculture, our laboratory also places a special emphasis on discovering new diagnostic, preventative and therapeutic strategies targeting cellular damage caused by environmental stressors that impair our land-water-food nexus.
Professor of Infectious Diseases of Animals and Director of the Post-graduate School of Infectious Diseases at the Department of Veterinary Medicine, University of Bari, Italy.
I am primarily interested in computational biology and bioinformatic approaches to biomarkers based on multi-variate, multi-modal gene signatures, especially in the context of cancer.
Presently, I am working as a Senior Research Scientist at Memorial Sloan Kettering Cancer Center, New York, USA. My research interest includes “epigenetics and transcriptional regulation”. My research work is focused on exploring microenvironment of high-grade tumors arise in the overall course of the disease and in relation to treatment.
During 2021-22, I worked as Postdoctoral Research Scientist at Columbia University, New York, US. My work was to explore differences between regulatory networks involved in cancer and normal tissues using bioinformatics and computational biology. Earlier, I was working as Post-Doc at TAGC, INSERM, Aix Marseille University, Marseille, France during 2018-21. My research work was focused on the Identification of Epromoters, promoters showing enhancer activity, like clusters in various stress conditions. We have developed a pipeline to identify Epromoter like clusters. During 2016-18, I worked as Research Associate at CSIR-Institute of Genomics & Integrative Biology, New Delhi, India. My work was focused on the identification and validation of genetic and epigenetic biomarkers for high altitude phenotypes using bioinformatics approaches. I pursued my Ph.D. work at the Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi, India, and earned my Ph.D. degree from NIU, India in 2016.
In my tenure, I have published around FIFTY Articles. In addition to this, I was awarded an Independent Research Project from the Indian Council of Medical Research, India. I was also an Invited Researcher (two times) at the Department of Medical Chemistry, Medical University of Vienna, Vienna, Austria. I was also awarded various travel grants from Indian and overseas funding agencies to present my research work.
Professor of Pathology and Immunology at the University of Verona, Italy. Dr. Constantin has long-standing expertise in vascular inflammation and leukocyte trafficking with particular focus on the central nervous system. She has a M.D. degree and Residency in Neurology from the University of Milan, and Ph.D. degree from the University of Verona. For her neuroimmunology studies she received several national and international awards. She was elected in the AcademiaNet for excellent woman academics.
Dr. Anup Pathania is an Assistant Professor at the University of Nebraska Medical Center (UNMC).
His research interests include non-coding RNAs in cancer, pharmacology, and immunology. He is currently investigating the underlying mechanisms in the stabilization of PD-L1 by exosomal non-coding RNAs in neuroblastoma cells within the tumor microenvironment.
Maria Carmen Collado (PhD 2005) holds a Research Scientist position at the Spanish National Research Council (CSIC) at the Institute of Agrochemistry and Food Technology (IATA-CSIC) in Valencia (Spain). Her research work is multidisciplinary and includes microbiology, food science, nutrition and human health. Her interests are focused on probiotics, microbiota and health and nutrition during pregnancy and early life period.
Chris Glasby is a specialist in the systematics – taxonomy, phylogeny and biogeography – of Annelida, specifically polychaetes (marine bristle worms). He is emeritus Curator of Annelids at the Museum & Art Gallery of the Northern Territory, Darwin and an Honorary Research Associate of the Australian Museum, Sydney.
Research Director of the Centre National de la Recherche Scientifique (CNRS); Lab leader of the Mammalian Cell Biology Unit at the Institute for Human Genetics (IGH) of the CNRS and University of Montpellier.
Principal research themes: Post-translational control of cell division cycle from quiescence to proliferation and differentiation of progenitor cells and multipotent stem cells from adult skeletal muscle.
Professor of Human Physiology, I'm a systems neuroscientist and neurologist by training. My current researches include the study of the cognitive aspects of motor control and the neural correlates of hierarchical learning in human and non-human primates. I'm also interested to multidimensional signal analysis and to the progress of neurotechnologies for developing innovative brain-computer interfaces.
Dr. Jiaqi Liang is a Researcher in the Department of Thoracic Surgery, Zhongshan Hospital, Fudan University. Her research predominantly focuses on the clinical and molecular research of lung cancer.
Principal Scientist, Atomwise. Adjunct associate professor of biochemistry and biophysics at Kansas State University. Research in computational/AI and structure-based drug design, biophotonics, machine learning for chemistry and drug discovery, protein crystallography.